HCSG (73) ARDT (69) MD (76) BKD (31) ⌘ Pro Terminal →

Sonida Senior Living Inc. (SNDA) — RQD Stock Rating Cockpit

$34.30 +0.15% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $34.24

Sonida Senior Living Inc. (SNDA) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $1.65B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SNDA Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SNDA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Sonida Senior Living Inc. (NYSE: SNDA) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $34.30 (+0.15% 1D, market cap $1.65B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, SNDA ranks #798 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SNDA compare to HCSG and ARDT in the Health Care sector?

▼

Within the Health Care sector (Hospital/Nursing Management), SNDA carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, HCSG (Healthcare Services Group Inc.) holds a B grade (73/100 RQD, P/E 28.2x, ROIC 11.6%, cap $1.66B) and ARDT (Ardent Health Inc.) posts a C+ grade (69/100 RQD, P/E 12.8x, ROIC 10.5%, cap $1.73B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SNDA?

▼

Per SNDA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001043000), Sonida Senior Living Inc. generated $381.1M in revenue (+25.2% YoY), -$72.5M in net income, and -$8.9M in free cash flow against $844.8M in total assets and $682.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $34.25 (-0.16%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-12.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNDA)Realized 20D OHLCV Swing Band: ±7%

Deterministic 5-Pillar Attribution (31/100 Composite)

🔍 WHY SNDA SCORES 31/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+12/20 pts (39% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+7/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$36.15-5.9% Next Q

Q2 (-2Q)

Grade E$34.03-1.4% Next Q

Q3 (-1Q)

Grade E$33.54+2.3% Next Q

Current

Grade E$34.30-9.4% Hist 90D α

Trajectory: E (39) → E (31)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SNDA Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SNDA currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($36.98) and Max Pain ($36.02) forces dealer call-delta covering toward $46.61.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SNDA• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “SNDA Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 31%NO 69%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

40.730 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

3 / 99-Pt Accounting

52-WEEK LASER RANGE48% OF RANGE

L: $25$34.30H: $44

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: C-RQD 12 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 9 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: ERQD 10 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on SNDA

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (60)

14.0% ROIC with 42.0% gross margin and -0.54% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (35)

Altman-Z 4.20 and Piotroski 3/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (20)

9/40 institutional & smart-money positioning score with 3/20 macro alignment.

Bull Case: Why Buyers Like SNDA

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNDA)

✓Walkthrough of SNDA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SNDA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -8.31%📐 HORIZONTAL RANGE

2026-11-02O $33.60H $34.30L $33.60C $34.30VOL 392.7K

RES: $46.86SUP: $32.04SMA50: $36.98SMA200: $36.43

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SNDA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SNDA Butterfly Map → + Track SNDA →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +25.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SNDA today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SNDA. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SNDA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNDA)

Health Care Rank #798 of 1016 ⚔️ HCSG vs SNDA Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SNDA vs. HCSG, ARDT, MD, BKD)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Sonida Senior Living Inc. (SNDA) ranks #798 by composite RQD confidence (31/100, grade E) and #295 by equity capitalization ($1.65B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 76/100 (B+) compared with SNDA at 31/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SNDA ACTIVE Sonida Senior Living Inc.	E	31/100	—	—	—	+0.15%	$1.65B	Benchmark Subject
HCSG Healthcare Services Group Inc.	B	73/100	28.2x	13.0%	11.6%	-0.65%	$1.66B	/hcsg-vs-snda →
ARDT Ardent Health Inc.	C+	69/100	12.8x	—	10.5%	-2.19%	$1.73B	/ardt-vs-snda →
MD Pediatrix Medical Group Inc.	B+	76/100	14.3x	—	33.6%	+2.19%	$2.37B	/md-vs-snda →
BKD Brookdale Senior Living Inc.	E	31/100	—	26.2%	0.3%	+1.17%	$2.45B	/bkd-vs-snda →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001043000

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Sonida Senior Living Inc. (SNDA) reported GAAP revenue of $381.1M (+25.2% vs. FY2024 revenue of $304.3M , and +49.3% cumulative change since FY2023) , GAAP net income of -$72.5M, operating cash flow of $24.4M, and free cash flow of -$8.9M (+66.9% YoY). On the balance sheet, SNDA closed FY2025 with $844.8M in total assets against $682.5M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$381.1M	-$72.5M	$24.4M	-$8.9M	$844.8M	$682.5M
FY2024 (FY)	2024-12-31	$304.3M	-$3.3M	-$1.8M	-$27.0M	$841.9M	$635.9M
FY2023 (FY)	2023-12-31	$255.3M	-$21.1M	$10.7M	$10.7M	—	—

3. SNDA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SNDA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does SNDA compare to HCSG and ARDT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for SNDA?

Where is SNDA trading relative to its 50-day, 200-day, and 52-week technical levels?

SNDA last traded at $34.30 (+0.15% on volume of 466,449 shares), positioning the stock -7.25% below its 50-day simple moving average ($36.98) and -5.85% below its 200-day simple moving average ($36.43). Across its 52-week range of $24.95 to $44.39, SNDA sits at the 48.1% percentile with a 14-day RSI of 40.7 (NEUTRAL RANGE) and an implied next-earnings move of ±7.0% ($31.90 to $36.70).

SNDA Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell SNDA stock right now?

Sonida Senior Living Inc. (SNDA) currently earns a Roarable Rating of E (Strong Sell — SELL) with 31/100 RQD Confidence. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.

What is SNDA's 12-month price target and RQD AI Jury consensus?

SNDA's 12-month base price target is $30.13 (range $23.5 to $46.61), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: SNDA RQD Cockpit SNDA 12M Forecast SNDA Earnings & Move SNDA Dividends & DRIP SNDA Insiders & 13F SNDA Whale Options SNDA Profit Sankey SNDA News & Why

ROARABLE RATING BRIEF • RQD 31/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

SNDA — Sonida Senior Living Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:28:20Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, SNDA carries an RQD Score of 31 out of 100, a letter grade of E, and the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are:

Fundamental Cash Engine (12 / 20): Per the Roarable RQD rating, this pillar reflects ROIC of 0% and FCF yield of -0.54%. The cash-generation signal is weak, meaning the business is not currently converting capital into returns that would support a valuation premium.
Whale / 13F Flow (6 / 20): The pillar label references institutional accumulation and options positioning. No underlying holder data is provided in the source data, so the score cannot be traced to specific positions.
Insider Conviction (3 / 20): The pillar label references SEC Form 4 and Congressional PTR cluster flow. No insider transaction detail is provided in the source data.
Macro Regime Fit (3 / 20): Per the Roarable RQD rating, beta is 1.0 with a sector-sensitivity component. The pillar indicates limited alignment with the current regime as scored.
Forensic Balance Sheet (7 / 20): Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 3/9, and Debt/Equity is 0.5. These readings point to elevated balance-sheet risk relative to the other pillars.

For a prospective investor evaluating the stock today, the implication is that the rating's weakest pillars (insider conviction and macro fit) and its low fundamental cash score offset any upside narrative. The forensic readings reinforce caution. Upside drivers cited in the source data are limited; the valuation tradeoff is that the stock trades at a price of 34.25 without reported earnings-based multiples available for comparison. The rating frames the stock as high-risk on the evidence provided, and this is an analytical reading, not personalized advice.

Business

Sonida Senior Living Inc. is a NYSE-listed issuer in the Health Care sector, within the Hospital/Nursing Management industry. Per the profile, the company operates in this industry with a market capitalization of $1.6B. The source data does not describe specific products, customers, or revenue-generating mechanics beyond the sector and industry classification.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$381.1M	$0.0M	$-72.5M	N/A	$-8.9M	$11.0M	$682.5M
FY 2024	$304.3M	$68.7M	$-3.3M	N/A	$-27.0M	$17.0M	$635.9M
FY 2023	$255.3M	$57.9M	$-21.1M	N/A	$10.7M	N/A	N/A

Per the SEC financials, revenue rose from $255.3M in FY 2023 to $381.1M in FY 2025, while net income was negative in each reported period. Per the market data, gross margin and operating margin are each 0%, and net margin is -19%. Per the Roarable RQD rating, ROIC is 0%, the Altman Z-Score is 2.5, and the Piotroski F-Score is 3/9. Debt reported in FY 2025 was $682.5M against cash of $11.0M, and the Debt/Equity ratio is 0.5 per the rating.

Recent Catalysts & News Wire Analysis

Per the news wire, the headlines carry the following signals:

RISK WATCH (red): A GuruFocus report on a 3.6% share decline, and a Zacks downgrade to "Strong Sell" reported by ad-hoc-news.de.
MARKET WIRE (yellow): A third-quarter earnings release date and conference call announcement (Yahoo Finance); a MarketBeat report on a "Hold" consensus rating; a TradingView note that the Q3'26 revenue estimate is 205.51M USD; and a MarketBeat report of a new position by Schwartz Investment Counsel Inc.

Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded for SNDA.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," with no butterfly links and no proprietary signals. No upstream or downstream dependencies are provided in the source data. Sector correlations and second-order bottlenecks cannot be established from the provided material. A prospective investor should note that the absence of mapped links means ripple effects are unquantified, not confirmed absent.

Open Questions

What are the company's P/E, EPS, and EV/EBITDA multiples, given that these are absent from the source data while the rating relies on cash-flow and balance-sheet measures?
What drove the net loss of $-72.5M in FY 2025 after operating income of $0.0M, and what is the reconciliation between them?
What is the FY 2023 cash and debt position, which is recorded as N/A?
What institutional and insider holdings underlie the whale-flow and insider-conviction pillar scores, given that the holders section is empty?
What do the third-quarter results show, given that only the release date and a revenue estimate are provided?

SNDA Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Sonida Senior Living Inc. (SNDA) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to SNDA Debate Forum (3) ↓

🔴 RISK WATCH GuruFocus • 5h ago

Sonida Senior Living Inc (SNDA) Shares Fall 3.6% -- What GF Scor

GuruFocus report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 8h ago

Sonida Senior Living Announces Third Quarter Earnings Release Date and Conference Call

Yahoo Finance report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 11h ago

Sonida Senior Living, Inc. (NYSE:SNDA) Stock Now Rated "Hold" by Wall Street Analysts

MarketBeat report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 14h ago

SNDA Q3'26 Earnings: revenue estimate is 205.51M USD

TradingView report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH ad-hoc-news.de • 17h ago

Zacks cuts Sonida Senior Living to Strong Sell for Sonida Senior Living stock

ad-hoc-news.de report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 20h ago

Sonida Senior Living, Inc. $SNDA Shares Newly Acquired by Schwartz Investment Counsel Inc.

MarketBeat report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 23h ago

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates

Yahoo Finance report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Traders Daily • 1d ago

(SNDA) as a Liquidity Pulse for Institutional Tactics

Stock Traders Daily report covering Sonida Senior Living Inc. (SNDA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SNDA Bull vs. Bear Conversation Board — What's Your Call at $34.30?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SNDA 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $30.14 (-12.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is SNDA (E • RQD 31/100) a Buy at $34.25?

Welcome to the SNDA (Sonida Senior Living Inc.) Roar Pit. Current RQD Composite is 31/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Hospital/Nursing Management. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $27.40 (-20.0%)

Spot @ $34.25

Pump the brakes on SNDA — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on SNDA, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Sonida Senior Living Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

QU QuantViper Verified K Arena Trader 🐂 BULLISH 🎯 Target: $40.42 (+18.0%)

Spot @ $34.25

SNDA cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on SNDA, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $34.25 (52-wk range $24.95 - $44.39), any beat on forward guidance forces shorts and underweight funds to chase.